| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α
|
Koukourakis, Michael I.
|
|
|
53 |
1 |
p. 8-14
|
artikel
|
| 2 |
Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α
|
Koukourakis, Michael I.
|
|
2003
|
53 |
1 |
p. 8-14
|
artikel
|
| 3 |
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan
|
Verschraegen, Claire F.
|
|
|
53 |
1 |
p. 1-7
|
artikel
|
| 4 |
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan
|
Verschraegen, Claire F.
|
|
2003
|
53 |
1 |
p. 1-7
|
artikel
|
| 5 |
Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study
|
Frasci, Giuseppe
|
|
2003
|
53 |
1 |
p. 25-32
|
artikel
|
| 6 |
Citrate enhances the protective effect of orally administered bismuth subnitrate against the nephrotoxicity of cis-diamminedichloroplatinum
|
Kondo, Yukihiro
|
|
2003
|
53 |
1 |
p. 33-38
|
artikel
|
| 7 |
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
|
Morales, Serafín
|
|
|
53 |
1 |
p. 75-81
|
artikel
|
| 8 |
Docetaxel plus epirubicin is a highly active, well-tolerated, first-line chemotherapy for metastatic breast cancer: results of a large, multicentre phase II study
|
Morales, Serafín
|
|
2003
|
53 |
1 |
p. 75-81
|
artikel
|
| 9 |
Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo
|
Donnelly, Erling T.
|
|
|
53 |
1 |
p. 43-50
|
artikel
|
| 10 |
Effects of RSR13 and oxygen on the cytotoxicity of cisplatin and carboplatin to EMT6 mouse mammary tumor cells in vitro and in vivo
|
Donnelly, Erling T.
|
|
2003
|
53 |
1 |
p. 43-50
|
artikel
|
| 11 |
Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line
|
Hata, Kohkichi
|
|
|
53 |
1 |
p. 68-74
|
artikel
|
| 12 |
Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line
|
Hata, Kohkichi
|
|
2003
|
53 |
1 |
p. 68-74
|
artikel
|
| 13 |
Fetal bovine serum, but not human serum, inhibits the in vitro cytotoxicity of ET-743 (Yondelis, trabectedin)
|
Tognon, Gianluca
|
|
2003
|
53 |
1 |
p. 89-90
|
artikel
|
| 14 |
Increased myelotoxicity of idarubicin: Is there a pharmacological basis?
|
Kroschinsky, Frank
|
|
|
53 |
1 |
p. 61-67
|
artikel
|
| 15 |
Increased myelotoxicity of idarubicin: is there a pharmacological basis?
|
Kroschinsky, Frank
|
|
2003
|
53 |
1 |
p. 61-67
|
artikel
|
| 16 |
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease
|
Hungria, Vania T. M.
|
|
|
53 |
1 |
p. 51-60
|
artikel
|
| 17 |
Metabolism of a cholesterol-rich microemulsion (LDE) in patients with multiple myeloma and a preliminary clinical study of LDE as a drug vehicle for the treatment of the disease
|
Hungria, Vania T. M.
|
|
2003
|
53 |
1 |
p. 51-60
|
artikel
|
| 18 |
Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent
|
Schroeder, Patricia E.
|
|
2003
|
53 |
1 |
p. 91-93
|
artikel
|
| 19 |
Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primates
|
Renbarger, Jamie
|
|
2003
|
53 |
1 |
p. 39-42
|
artikel
|
| 20 |
Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway
|
Zhang, Xian-Ming
|
|
|
53 |
1 |
p. 82-88
|
artikel
|
| 21 |
Quercetin inhibits the invasion of murine melanoma B16-BL6 cells by decreasing pro-MMP-9 via the PKC pathway
|
Zhang, Xian-Ming
|
|
2003
|
53 |
1 |
p. 82-88
|
artikel
|
| 22 |
Synergistic effects of co-administration of angiotensin 1–7 and Neupogen on hematopoietic recovery in mice
|
Ellefson, Dolph D.
|
|
2003
|
53 |
1 |
p. 15-24
|
artikel
|
Tijdschrift beschrijving